SOURCES SOUGHT
65 -- Biological Product
- Notice Date
- 10/27/2009
- Notice Type
- Sources Sought
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PB-(HL)-2010-013-DDC
- Archive Date
- 11/26/2009
- Point of Contact
- Deborah - Coulter, Phone: (301) 435-0368
- E-Mail Address
-
dc143b@nih.gov
(dc143b@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This Sources Sought Notice (SS) is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the National Heart, Lung, and Blood Institute (NHLBI). The purpose of this SS is to identify qualified small business concerns [including Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone) Small Businesses, Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-owned Small Businesses (SDVOSB] that are interested in and capable of providing the below Anti Body manufactured by Life Technologies Corporation. The NHLBI does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted. As a result of this Sources Sought notice, the NHLBI may issue a Request for Quote (RFQ). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against NHLBI shall arise as a result of a response to this Sources Sought notice or the NHLBI’s use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement. The NHLBI is seeking capability statements from all eligible small business concerns [particularly Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone) Small Businesses, Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-owned Small Businesses (SDVOSB)] under the North American Industry Classification System (NAICS) code 325414 with a size standard of _500__ number of employees / per annum. Based on the responses received from this SOURCES SOUGHT announcement, the proposed acquisition may be solicited as a Total Small Business Set-Aside. All eligible small business concerns responding to this Sources Sought Announcement must have the capabilities to provide the below listed products within 2 to 5 days after receipt of purchase order. Biological Product Description: CD103, Mouse Anti-Human, (TRI-COLOR®) Cat. No. MHCD10306 CD103, Mouse Anti-Human, (TRI-COLOR); TRI-COLOR conjugated Monoclonal antibody specific to Human CD103. This antibody is validated for use in Flow Cytometry. Anti-CD103 recognizes the expressed product of the ITGAE gene. CD20, Mouse Anti-Human, (PE-Cy5.5) Cat. No. MHCD2018 CD20, Mouse Anti-Human, (PE-Cy5.5); PE/Cy5.5 conjugated Monoclonal antibody specific to Human CD20. This antibody is validated for use in Flow Cytometry. Anti-CD20 recognizes the expressed product of the MS4A1 gene. CD38, Mouse Anti-Human, (PE-TR) Cat. No. MHCD3817 CD38, Mouse Anti-Human, (PE-TR); PE/Texas Red conjugated Monoclonal antibody specific to Human CD38. This antibody is validated for use in Flow Cytometry. Anti-CD38 recognizes the expressed product of the CD38 gene. CD39, Mouse anti-Human, (Alexa Fluor® 488) Cat. No. MHCD3920 According to the literature, this antibody recognizes CD39, also known as ecto-nucleotidase (NTDPase1), an ADPase and ATPase found on the surface of endothelial cells, normal lymphocytes, and other leukocytes. HLA-DR (Class II), Mouse Anti-Human, (PE-TR) Cat. No. MHLDR17 HLA-DR (Class II), Mouse Anti-Human, (PE-TR); PE/Texas Red conjugated Monoclonal antibody specific to Human HLA-DR. This antibody is validated for use in Flow Cytometry. Anti-HLA-DR recognizes the expressed product of the HLA-DRA gene, also known as HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5. HLA-DR (Class II), Mouse Anti-Human, (PE-Cy5.5) Cat. No. MHLDR18 HLA-DR (Class II), Mouse Anti-Human, (PE-Cy5.5); PE/Cy5.5 conjugated Monoclonal antibody specific to Human HLA-DR. This antibody is validated for use in Flow Cytometry. Anti-HLA-DR recognizes the expressed product of the HLA-DRA gene. CD 4, mouse anti-human, (Qdot® 605 conjugated) Cat. No. Q10008 According to the literature this antibody recognizes the CD4 antigen also known as T4 and L3T4. CD4 serves as a co-receptor during T cell activation through the binding of MHC Class II molecules. CD4 is also the receptor for HIV. CD 8, mouse anti-human, (Qdot® 605) Cat. No. Q10009 According to the literature this antibody recognizes the CD8 antigen also known as T8 and Lyt2,3. This antibody recognizes the α chain alone as well as the αβ heterodimer. CD27, mouse anti-human, Qdot® 655 conjugate Cat. No. Q10066 According to the literature this antibody recognizes the CD27 antigen. CD27 is a member of the TNFR/NGFR family that binds to CD70. CD27 is expressed on some B cells, a subset of thymocytes, NK cells and T cells. CD45, Mouse anti-human, Qdot™ 800 conjugate Cat. No. Q10156 CD45, Mouse anti-Human, Qdot™ 800 conjugate: Qdot™ 800 conjugated monoclonal antibody specific to Human CD450. This antibody is validated for use in Flow Cytometry. Anti-CD45 recognizes the expressed product of the CD45 gene. CD19, Mouse anti-human, Qdot® 655 conjugate Cat. No. Q10179 CD19, Mouse anti-Human, Qdot® 655 conjugate: Qdot® 655 conjugated monoclonal antibody specific to Human CD19. This antibody is validated for use in Flow Cytometry. Anti-CD19 recognizes the expressed product of the CD19 gene. TNFα, Rat anti-Human, (PE Alexa Fluor® 700) Cat. No. RHTNFA24 According to the literature this antibody binds to human tumor necrosis factor. Granzyme B, Mouse Anti-Human, (PE-Cy5.5) Cat. No. GRB18 Granzyme B, Mouse Anti-Human, (PE-Cy5.5); PE/Cy5.5 conjugated Monoclonal antibody specific to Human Granzyme B. This antibody is validated for use in Flow Cytometry. Anti-Granzyme B recognizes the expressed product of the GZMB gene. CD57, Mouse Anti-Human, (FITC) Cat. No. MHCD5701-4 CD57, Mouse Anti-Human, (FITC); FITC conjugated Monoclonal antibody specific to Human CD57 (NK cells). This antibody is validated for use in Flow Cytometry. Anti-CD57 (NK cells) recognizes the expressed product of the B3GAT1 gene. CD10, Mouse anti-human, Qdot® 605 conjugate Cat. No. Q10153 CD10, Mouse anti-Human, Qdot® 605 conjugate: Qdot® 605 conjugated monoclonal antibody specific to Human CD10. This antibody is validated for use in Flow Cytometry. Anti-CD10 recognizes the expressed product of the CD10 gene. CD11c, Mouse andi-Human, (PE-Cy5.5) Cat. No. MHCD11C18 CD11c, Mouse anti-Human (PE-Cy5.5):PE-Cy5.5 conjugated monoclonal antibody specific to Human CD11c. This antibody is validated for use in Flow Cytometry. Anti-CD11c recognizes the expressed product of the CD11c gene. Interested parties are expected to review this notice to familiarize yourself with the requirements of this project; failure to do so will be at your firm’s own risk. Interested qualified small business organizations should submit a tailored capability statement for this requirement, not to exceed 20 single-sided pages (including if applicable attachments, resumes, charts, etc.) presented in single-space and using a 12-point font size minimum, that clearly details the ability to perform the aspects of the notice described above. All proprietary information should be marked as such. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern’s name and address). Responses will be reviewed only by NIH personnel and will be held in a confidential manner. All capability Statements sent in response to this SOURCES SOUGHT notice must be submitted electronically (via email) to Deborah Coulter Contract Specialist, at coulterd@nhlbi.nih.gov in either MS Word or Adobe Portable Document Format (PDF), by November 11, 2009, 7:30 AM, EST. All responses must be received by the specified due date and time in order to be considered.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-PB-(HL)-2010-013-DDC/listing.html)
- Place of Performance
- Address: NIH 10 Center Drive, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN01992905-W 20091029/091027234940-f5559559d10f953564b1f0dfa83323b3 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |